Clifford Chance has advised Huitongda Network Co., Ltd. on the deal while Cooley advised the joint sponsors and underwriters. Founded in late 2010, Nanjing-based Huitongda is...
Huitongda Network Co., Ltd.’s US$284 Million Hong Kong Initial Public Offering and Listing
Keymed Biosciences’ US$400 Million Hong Kong IPO
O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc....